论文部分内容阅读
为探讨血浆纤溶酶原激活物抑制物 - 1与糖尿病视网膜病变的关系。本文选取 12 6例糖尿病视网膜病变患者 ,6 6例其它眼病患者 (非血管性疾病 ) ,10 0例健康自愿者 ,用发色底物法测定其血浆纤溶酶原激活物抑制物 - 1活性。12 6例患者的血浆纤溶酶激活物抑制物 -活性显著高于其它
To investigate the relationship between plasma plasminogen activator inhibitor - 1 and diabetic retinopathy. In this paper, 126 cases of diabetic retinopathy, 66 cases of other ocular diseases (non-vascular diseases) and 100 healthy volunteers were enrolled in this study. Plasma plasminogen activator inhibitor-1 activity . Twelve of the 6 patients had plasma plasminogen activator inhibitor-activity significantly higher than the others